ImmuCell Corporation (ICCC) News
Follow ImmuCell Corporation (ICCC) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
ImmuCell Schedules Quarterly Results Announcement for November 13
ImmuCell said it will announce unaudited financial results for the quarter ended September 30, 2026, with a conference call scheduled for November 13, 2026, at 9:00 a.m. ET.
EQUITY | Nov 06, 2026, 09:06 PM UTC
M
ImmuCell Reports Q3 Sales Up 46% to $8.0 Million
Preliminary, unaudited third-quarter sales were $8.0 million, up 46.0% year over year. Domestic sales rose 29.2% to $6.9 million; nine-month sales increased 27.8% to $25.6 million.
EARNINGS | Oct 13, 2026, 10:13 AM UTC
M
ImmuCell reports 46% product sales increase in Q3 2026
ImmuCell says preliminary, unaudited product sales rose 46% in the third quarter of 2026.
EQUITY | Oct 12, 2026, 08:05 PM UTC
L
ImmuCell reports Q2 2026 results, expands capacity plans
ImmuCell reported second-quarter product sales of $7.2 million, net income of $1.8 million and gross margin of 33.9%, while planning $8 million in capacity investments.
EARNINGS | Aug 14, 2026, 03:51 PM UTC
L
ImmuCell reports unaudited quarterly financial results
ImmuCell announces unaudited financial results for the quarter ended June 30, 2026.
EARNINGS | Aug 13, 2026, 08:09 PM UTC
L
Immucell reports preliminary Q2 revenue $7.2M
"Total sales for the three months ended June 30, 2026 were $7.2 million, an 11.5% increase compared to the three months ended June 30, 2025, driven by a 27.7% increase in domestic sales compared to 2025," said Timothy Fi
EARNINGS | Jul 09, 2026, 08:12 PM UTC
L
ICCC: CEO Buys 8,000 Shares
IMMUCELL CORP CEO te Boekhorst Paul Francis Olivier P buys 8,000 shares at $9.495
EARNINGS | Jun 22, 2026, 12:34 PM UTC